Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）
Recruiting · NCT06647940 · Registry updated 2024-10-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial） | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2024-10-22 | NCT06647940 |
12 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dongguan People's Hospital | Dongguan | China | 1 |
| Fifth Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 1 |
| Fifth Affiliated Hospital of Sun Yat-sen University | Zhuhai | China | 1 |
| First Affiliated Hospital of Shantou University Medical College. | Shantou | China | 1 |
| First People's Hospital of Guangzhou | Guangzhou | China | 1 |
| Gansu Cancer Hospital | Lanzhou | China | 2 |
| Guangdong Provincial Hospital of Traditional Chinese Medicine | Guangzhou | China | 8 |
| Second Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 5 |
| Shenzhen People's Hospital | Shenzhen | China | 25 |
| Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University, | Guangzhou | China | 1 |
| Zhaoqing first people's hospital | Zhaoqing | China | 2 |